Eastern Bank Bristol Myers Squibb CO Transaction History

Eastern Bank

$5.44 Billion
Q3 2024

A detailed history of Eastern Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eastern Bank holds 45,290 shares of BMY stock, worth $2.57 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

45,290

Previous 5,555 715.3%

Holding current value

$2.57 Million

Previous $230,000 918.7%

% of portfolio

0.04%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$39.66 - $51.75 $1.58 Million - $2.06 Million	39,735 Added 715.3%	45,290 $2.34 Million
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $16,100 - $21,196	-400 Reduced 6.72%	5,555 $230,000
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $25,161 - $30,024	-519 Reduced 8.02%	5,955 $305,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $6,562 - $7,286	-103 Reduced 1.57%	6,474 $414,000
Q1 2023 Apr 19, 2023	SELL	$65.71 - $74.53 $74,449 - $84,442	-1,133 Reduced 14.7%	6,577 $455,000
Q3 2022 Oct 19, 2022	SELL	$0.13 - $76.84 $50 - $29,583	-385 Reduced 4.76%	7,710 $548,000
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $68,989 - $75,981	-950 Reduced 10.5%	8,095 $624,000
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $626,050 - $750,690	-10,183 Reduced 52.96%	9,045 $661,000
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $708,559 - $826,014	13,212 Added 219.61%	19,228 $1.2 Million
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $1,952 - $2,287	-33 Reduced 0.55%	6,016 $356,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $90,315 - $101,578	-1,522 Reduced 20.1%	6,049 $382,000
Q4 2020 Jan 20, 2021	SELL	$57.74 - $65.43 $74,311 - $84,208	-1,287 Reduced 14.53%	7,571 $469,000
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $7,178 - $7,955	125 Added 1.43%	8,858 $534,000
Q2 2020 Jul 21, 2020	SELL	$54.82 - $64.09 $39,799 - $46,529	-726 Reduced 7.68%	8,733 $513,000
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $11,600 - $16,857	-250 Reduced 2.57%	9,459 $526,000
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $92,170 - $120,227	1,873 Added 23.9%	9,709 $623,000
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $42,770 - $50,710	-1,000 Reduced 11.32%	7,836 $398,000
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $117,618 - $130,060	-2,636 Reduced 22.98%	8,836 $400,000
Q1 2019 Apr 18, 2019	SELL	$45.12 - $53.8 $181,608 - $216,545	-4,025 Reduced 25.97%	11,472 $548,000
Q4 2018 Jan 18, 2019	SELL	$48.76 - $63.23 $69,726 - $90,418	-1,430 Reduced 8.45%	15,497 $806,000
Q3 2018 Oct 16, 2018	SELL	$55.19 - $62.25 $242,394 - $273,402	-4,392 Reduced 20.6%	16,927 $1.05 Million
Q2 2018 Jul 18, 2018	SELL	$50.53 - $62.98 $462,854 - $576,896	-9,160 Reduced 30.05%	21,319 $1.18 Million
Q1 2018 Apr 09, 2018	SELL	$59.92 - $68.98 $13.8 Million - $15.9 Million	-230,487 Reduced 88.32%	30,479 $1.93 Million
Q4 2017 Jan 22, 2018	BUY	$59.94 - $65.35 $26,673 - $29,080	445 Added 0.17%	260,966 $16 Million
Q3 2017 Oct 24, 2017	BUY	$55.23 - $63.74 $14.4 Million - $16.6 Million	260,521	260,521 $16.6 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.

Account